The present invention provides novel crystalline and amorphous forms of asenapine maleate, pharmaceutical compositions comprising same, methods for their preparation and use thereof as an antipsychotic.Nouvelles formes cristallines ou amorphes de maléate dasénapine compositions pharmaceutiques les renfermant, procédés de préparation et utilisation comme antipsychotique.